Concentration: 5 mg per mL 1 unit on a U-100 syringe = 0.05 mg (50 mcg) At 5 mg/mL, the 0.25 mg starting dose requires only 5 units
FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors Eli Lilly The FDA approved Eli Lilly and Companys Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors
InBody Scan: Next, we perform a detailed body composition scan to measure weight, muscle mass, and body fat percentage, so we can track your progress accurately
Severe pain under your right ribcage that spreads to your shoulder or back, which could suggest gallbladder problems
It also slows digestion (stomach emptying), which helps control appetite
Medical Disclaimer This content is for educational purposes only and does not constitute medical advice
